Drug
Tadalafil 5Mg Tab
Tadalafil 5Mg Tab is a pharmaceutical drug with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
1
33%
Ph phase_1
2
67%
Phase Distribution
2
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 1Safety & dosage
2(66.7%)
N/ANon-phased studies
1(33.3%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
50.0%
1 of 2 finished
Non-Completion Rate
50.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(1)
Terminated(1)
Other(1)
Detailed Status
Withdrawn1
Completed1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 1
Trials by Phase
Phase 12 (66.7%)
N/A1 (33.3%)
Trials by Status
withdrawn133%
completed133%
unknown133%
Recent Activity
0 active trials
Showing 3 of 3
completedphase_1
Efficacy and Tolerability of Tadalafil Versus Darifenacin in Management of Ureteric Stent-Related LUTS
NCT07206706
withdrawnphase_1
The Phosphodiesterase Inhibitor Tadalafil as an Adjunct to Antidepressants in Major Depressive Disorder Patients
NCT05030623
unknownnot_applicable
Combined Effect of Continuous and Interval in Addition to Tadalafil Drug on Erectile Dysfunction
NCT04623840
Clinical Trials (3)
Showing 3 of 3 trials
NCT07206706Phase 1
Efficacy and Tolerability of Tadalafil Versus Darifenacin in Management of Ureteric Stent-Related LUTS
NCT05030623Phase 1
The Phosphodiesterase Inhibitor Tadalafil as an Adjunct to Antidepressants in Major Depressive Disorder Patients
NCT04623840Not Applicable
Combined Effect of Continuous and Interval in Addition to Tadalafil Drug on Erectile Dysfunction
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3